Table 2.

Distribution of total disease burden associated with exposure to endocrine-disrupting chemicals in the US according to race/ethnicity (base case estimates)

	Burden of disease & percentage of total cases across all race/ethnicity categories
Exposure and related outcome	Non-Hispanic White	Non-Hispanic Black	Mexican American	Other Hispanic	Other/Multiracial
Polybrominateddiphenyl ethers -(PBDE) IQ Point Loss and Intellectual Disability cases	IQ Loss: 5.1 million	IQ Loss: 1.6 million	IQ Loss: 1.4 million		IQ Loss: 1.6 million
	IQ cases: 22,400 (52.3%)	IQ cases: 7,300 (17.0%)	IQ cases: 5,800 (14.0%)		IQ cases: 7,200 (16.7%)
Organophosphate pesticides (OP)-IQ Point Loss and Intellectual Disability cases	IQ Loss: 834,300	IQ Loss: 281,200	IQ Loss: 262,200	IQ Loss: 232,500	IQ Loss: 277,500
	IQ cases: 3,470 (44.2%)	IQ cases: 1,200 (14.9%)	IQ cases: 1,100 (13.4%)	IQ cases: 1,000 (12.3%)	IQ cases: 1,340 (14.7%)
Dichlorodiphenyldichloroethylene (DDE) - Childhood overweight	108 (5.3%)	61 (3.0%)	1,600 (79.1%)		255 (12.6%)
Dichlorodiphenyldichloroethylene (DDE) – Adult diabetes	0 (0%)	10,400 (26.5%)	16,980 (43.2%)		11,900 (30.3%)
Di-2-ethylhexylphthalate (DEHP)-Adult obesity	4,180 (68.3%)	1,280 (20.9%)	604 (9.9%)	59 (1.0%)	0 (0%)
Di-2-ethylhexylphthalate (DEHP)-Adult diabetes	468 (12.2%)	2,850 (74.5%)	461 (12.0%)	47 (1.2%)	0 (0%)
Bisphenol A - Childhood obesity	16,400 (48.4%)	7,730 (22.8%)	6,780 (20.0%)	1,322 (3.9%)	1,620 (4.8%)
Polybrominateddiphenyl ethers (PBDE) - Testicular cancer	2,320 (64.7%)	445 (12.4%)	546 (15.2%)		274 (7.6%)
Polybrominateddiphenyl ethers (PBDE) - Cryptorchidism	2,750 (66.3%)	217 (5.2%)	194 (4.7%)		990 (23.8%)
Phthalates - Low testosterone, Resulting in Increased Early Mortality	15,540 (77.3%)	1,310 (6.5%)	1,740 (8.7%)	105 (0.5%)	1,415 (7.0%) 13
Dichlorodiphenyldichloroethylene (DDE) - Fibroids	17,700 (34.6%)	9,460 (18.5%)	16,270 (31.8%)		7,770 (15.2%)
Di-2-ethylhexylphthalate (DEHP) - Endometriosis	46,890 (56.7%)	12,900 (15.6%)	14,530 (17.6%)	1,790 (2.2%)	6,640 (8.0%)